Analyst Recommendations

Guggenheim analyst issues NEUTRAL recommendation for BNTC on June 10, 2026 10:50AM ET. The previous analyst recommendation was Buy.BNTC was trading at $10.81 at issue of the analyst...

June 10, 2026   BNTC -4.02%

Oppenheimer analyst issues OUTPERFORM recommendation for DTIL on June 9, 2026 10:52AM ET. DTIL was trading at $6.77 at issue of the analyst recommendation.The overall analyst consensus :...

June 9, 2026   DTIL -3.35%

ThinkEquity analyst issues BUY recommendation for GAME on June 8, 2026 10:34AM ET. GAME was trading at $0.3981 at issue of the analyst recommendation.The overall analyst consensus :...

June 8, 2026   GAME -1.24%

Piper Sandler analyst issues NEUTRAL recommendation for JVA on June 8, 2026 08:01AM ET. JVA was trading at $4.285 at issue of the analyst recommendation.The overall analyst consensus...

June 8, 2026   JVA -0.70%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for GRRR on June 4, 2026 02:02PM ET. The previous analyst recommendation was Overweight.GRRR was trading at $18.74 at issue of the...

June 4, 2026   GRRR 1.09%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for SNSE on June 4, 2026 11:00AM ET. The previous analyst recommendation was Overweight.SNSE was trading at $15.845 at issue of the...

June 4, 2026   SNSE -7.60%

Needham analyst issues BUY recommendation for QMCO on June 3, 2026 10:58AM ET. The previous analyst recommendation was Buy.QMCO was trading at $12.54 at issue of the analyst...

June 3, 2026   QMCO -3.18%

H.C. Wainwright analyst issues BUY recommendation for AKTS on June 2, 2026 03:44PM ET. The previous analyst recommendation was Buy.AKTS was trading at $19.4943 at issue of the...

June 2, 2026   AKTS -1.26%

H.C. Wainwright analyst issues BUY recommendation for MNPR on June 2, 2026 10:58AM ET. The previous analyst recommendation was Buy.MNPR was trading at $64.4 at issue of the...

June 2, 2026   MNPR -1.34%

H.C. Wainwright analyst issues BUY recommendation for DRUG on June 2, 2026 10:57AM ET. The previous analyst recommendation was Buy.DRUG was trading at $81.02 at issue of the...

June 2, 2026   DRUG -9.50%